Search by Drug Name or NDC
NDC 41250-0374-71 migraine formula 250; 250; 65 mg/1; mg/1; mg/1 Details
migraine formula 250; 250; 65 mg/1; mg/1; mg/1
migraine formula is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Meijer Distribution Inc. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.
Product Information
| NDC | 41250-0374 |
|---|---|
| Product ID | 41250-374_22236522-a426-4ec9-869e-d8e22cc45493 |
| Associated GPIs | 64990003200350 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | migraine formula |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Acetaminophen, Aspirin, Caffeine |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 250; 250; 65 |
| Active Ingredient Units | mg/1; mg/1; mg/1 |
| Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
| Labeler Name | Meijer Distribution Inc |
| Pharmaceutical Class | Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA075794 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 41250-0374-71 (41250037471)
| NDC Package Code | 41250-374-71 |
|---|---|
| Billing NDC | 41250037471 |
| Package | 1 BOTTLE in 1 CARTON (41250-374-71) / 50 TABLET, FILM COATED in 1 BOTTLE |
| Marketing Start Date | 2002-04-30 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |